Earnings Call · Q2 FY2022·2022-08-14

Q2 22EPS +22.22%·Rev n/aQ1 22EPS +17.24%·Rev n/aQ4 21EPS +6.67%·Rev n/aQ3 21EPS +12.82%·Rev n/a⚠ consensus missing

Trevi Therapeutics, Inc. TRVI

Jennifer Good — Chief Executive Officer

Lisa Delfini — Chief Financial Officer

−3.7%1d on move date−5.4% vs SPY3d−13.3%5d−12.2%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more TRVI calls or request research access.

More TRVI calls Browse calls Request research access